semaglutide tirzepatide retatrutide Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and on MC4R deficient obesity and their comparison Semaglutide vs Tirzepatide vs Retatrutide

H.MillerB.ChristensenA.LevineM

What you put on your plate matters just as much as whats happening inside your body. She breaks down the top foods to pile your plate with or leave on the shelf

It is also listed on the PBS for patients who fulfill the following key clinical criteria: an eGFR of 25 mL/min/1.73 m 2 or greater an ACR of 22.6 mg/mmol or greater must be on a stable dose of either an ACE inhibitor or ARB must not have established heart failure with reduced ejection fraction must be on an SGLT-2 inhibitor unless medically contraindicated or intolerant (please refer to the full PBS clinical criteria at: Combination therapy Some evidence suggests that combination therapy with SGLT-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and CKD reduces the risk of CV events and the mineralocorticoid receptor antagonist-associated risk of hyperkalaemia without a significant interaction between the two drugs

12 , e742 (2022)